No Data
TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating
Roivant Sciences (ROIV) Receives a Buy From TD Cowen
Earnings Preview: ROIV to Report Financial Results Pre-market on November 12
$Roivant Sciences(ROIV.US)$ is scheduled to release its financial results pre-market on November 12 ET. Earnings PreviewAnalysts estimate $Roivant Sciences(ROIV.US)$ to post revenue of USD48.63M for 2
Organon: FDA Extends Vtama Atopic-Dermatitis Review to March
Express News | Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024
Press Release: Organon Completes Acquisition of Dermavant, Including Innovative Dermatologic Therapy, VTAMA(R) (Tapinarof) Cream, 1%
No Data
No Data